Lana Yin Hui Lai - Concepedia

Author

Lana Yin Hui Lai

Also Known As

L. Lai, L. Y. H. Lai, L.Y.H. Lai, LYH Lai, Lai, L. Y. H., Lai, Lana, Lana Lai, Lana Y H Lai, Lana Y. H. Lai, Lana Y.H. Lai

Publications

619

Citations

H-Index

Concepts

All Affiliations

University of Manchester Janssen (United States)University of Oxford Erasmus MC Institut Universitari d'Investigació en Atenció Primària Jordi Gol

About

Lana Yin Hui Lai is an author at University of Manchester specializing in medicine, preventive medicine, and bias.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	34
2	Engineering	1	1	13
3	Public Health	1	1	13
4	Epidemiology	1	1	13
5	Pharmacology	1	1	21

Lana Yin Hui Lai

Publications

430

Citations

H-Index

Page 1

	Year	Citations
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study Albert Prats‐Uribe, Anthony G. Sena, Lana Yin Hui Lai, BMJ	2021	70
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries Eng Hooi Tan, Anthony G. Sena, Albert Prats‐Uribe, Lara D. Veeken	2021	52
Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience Talita Duarte‐Salles, David Vizcaya, Andrea Pistillo, PEDIATRICS	2021	47
Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France, Germany, Spain, South Korea and the United States: an international network cohort study Talita Duarte‐Salles, David Vizcaya, Andrea Pistillo,	2020	33
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS Kristin Kostka, Talita Duarte‐Salles, Albert Prats‐Uribe, Clinical Epidemiology	2022	25
Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom Martina Recalde, Elena Roel, Andrea Pistillo, International Journal of Obesity	2021	23
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study Erica A. Voss, Azza Shoaibi, Lana Yin Hui Lai, EClinicalMedicine	2023	23
A Patient-reported Outcome Measure for Effect of Glucocorticoid Therapy in Adults with Inflammatory Diseases Is Needed: Report from the OMERACT 2016 Special Interest Group Rachel Black, Joanna Robson, Susan M. Goodman, The Journal of Rheumatology	2017	22
CYP2C19 genotypes and their impact on clopidogrel responsiveness in percutaneous coronary intervention Melissa Mejin, Wen Ni Tiong, Lana Yin Hui Lai, International Journal of Clinical Pharmacy Percutaneous Coronary InterventionCardiovascular DiseasePharmacologyCardiovascular PharmacologyClopidogrel Responsiveness	2013	21
Vaccine Safety Surveillance Using Routinely Collected Healthcare Data—An Empirical Evaluation of Epidemiological Designs Martijn J. Schuemie, Faaizah Arshad, Nicole Pratt, Frontiers in Pharmacology	2022	18

Page 1